Table 2.
Inputs for the scenario testing the impact of increasing diagnosis and treatment of HCV
| Inputs | 2013 (Base) | 2014 | 2016 | 2018 and after |
|---|---|---|---|---|
| SVR G1 |
70% |
80% |
95% |
95% |
| SVR G2 |
70% |
85% |
95% |
95% |
| SVR G3 |
70% |
70% |
80% |
90% |
| SVR G4 |
48% |
80% |
95% |
95% |
| Age |
15 - 64 |
15 - 64 |
15 - 69 |
15 - 74 |
| Eligibility |
60% |
60% - 80% |
80% |
95% |
| Treated |
5430 |
8150 [F2] |
10190 [F2] |
11710 [F1] |
| Diagnosed |
5600 |
8400 |
13430 |
13430 |
| Age | 15 - 64 | 15 - 69 | 15 - 74 | 15 - 74 |